Quality healthcare is an integral part of the community and this includes ensuring that our senior citizens receive the best possible treatment and care when the time comes to place their well-being in the hands of another. Mark Rivkin has spent a great deal of time and capital investing in charities that enrich the health of people around the world, and one such example is the Baycrest Foundation.
Baycrest is a research and education hospital in Toronto, Ontario, Canada, and they are fully affiliated with the University of Toronto. Headquartered on a 22-acre campus, Baycrest is the global leader in developing and providing innovations in aging and brain health. Specialties of the institution include a comprehensive system of care for aging patients, one of the world’s top research institutes in cognitive neuroscience, dedicated centres focused on age-related illness, and unmatched global knowledge exchange and commercialization capacity. Baycrest has been chosen to lead a Canadian and North American initiative for developing new innovations in long-term senior care, and they were recently selected by Neurological Health Charities of Canada as a national award recipient for innovation and leadership in aging and brain health.
The Baycrest Foundation provides crucial support for this fine academic health science centre, and charitable funding goes towards top-quality healthcare for aging patients, innovative research and continued education.
As a Toronto native, Mark Rivkin will always strive to help Canadian charities and non-profit organizations, and the Baycrest Foundation is one of his local favorites. The mission of the Baycrest Foundation is to enrich the quality of life by supporting programs and services that promote superior care, research and education in the field of aging. This is certainly a cause for which Mark Rivkin is glad to show his continued support. Visit Baycrest.org for more information and to learn more about showing your support. You can also follow them on Twitter @Baycrest for social updates.